Esperion Therapeutics Earning Date (ESPR)

USA |NASDAQ |USD

ESPR Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 21, 2022 Dec 2021 $-2.43 - $-3.89
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 21, 2022 Dec 2021 $16.01M - $9.64M

Esperion Therapeutics's next earnings date is Monday, Feb 21, 2022 for the fiscal quarter ending Dec 2021.

ESPR Earnings Date & History Chart

ESPR Earnings & Revenue Forecast

ESPR Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $-2.43 $-2.83 $-1.65
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 11 $-10.29 $-11.02 $-9.05
Dec 2022 11 $-5.23 $-9.00 $1.28

ESPR Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 6 / 2 $-2.57 $-2.55 $-2.51
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 7 / 2 $-10.50 $-10.48 $-10.63
Dec 2022 7 / 2 $-5.58 $-5.04 $-5.34

ESPR Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 9 $16.01M $12.25M $28.89M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 11 $77.74M $71.81M $102.26M
Dec 2022 11 $119.74M $53.96M $414.50M

ESPR Earnings Date & Revenue History

ESPR Earnings History

|
Show More
Show More

ESPR Revenue History

|
Show More
Show More

Esperion Therapeutics Next Earnings Date & Report

ESPR Next Earnings Date & Report Preview: Dec 2021 (FQ)

ESPR's next earnings date is Monday, Feb 21, 2022 for the fiscal quarter ending Dec 31, 2021.

According to analysts, the average EPS estimation for Esperion Therapeutics's next quarterly earnings is $-2.43, with a low EPS estimation of $-2.83, and a high estimation of $-1.65.

Over the last 1 month, EPS estimates have seen 6 upward revisions and 2 downward. The EPS 1 month trend is $-2.57, the last 2 month trend is $-2.55, and the 3 month trend is $-2.51.

Based on analysts, the average revenue estimation is $16.01M, with a low revenue estimation of $12.25M, and a high estimation of $28.89M.

Esperion Therapeutics Previous Earnings Dates & Reports

ESPR Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Esperion Therapeutics's previous earnings date was Nov 2, 2021 for its fiscal quarter ended Sep 30, 2021.

ESPR Previous Earnings Date & Report Recap: Dec 2020 (FY)

Esperion Therapeutics's previous annual earnings date was Feb 23, 2021 for its fiscal year ended Dec 31, 2020.

ESPR's earnings per share (EPS) was $-5.48, missing the consensus analysts forecast of $-5.04 by 8.73% , and lower than the previous year's EPS (Dec 2019) by 47.31%.

Revenues were $227.55M, worse than the forecast of $230.35M by -1.22%, and up by 53.37% from previous year's revenue.

The company reported a net income of $-143.55M.

Esperion Therapeutics reported a free cash flow of $-98.55M for its fiscal year, compared to $-71.29M a year ago.

The company ended the fiscal year with $181.95M in total debt, an increase of 11541.33% compared to the previous year.